CAREFUSION 303

Manufacturer adverse-event records for CAREFUSION 303 come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2010–2025 · mid-book · quiet Death-code · injury-light

Injury-mix signature

CAREFUSION 303 is lighter on Injury codes

Injury-coded event_type share is 0.0% (injury-light tercile) beside 0.02% Death-coded (quiet). Volume band: mid.

What the Injury-mix reading shows for CAREFUSION 303

The standout signal for CAREFUSION 303 is Injury-mix: 0.0% Injury-coded (injury-light) beside 0.02% Death-coded, on a mid-book footprint.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for CAREFUSION 303. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 4 device types, led in this extract by Malfunction at 8,144 (99.9% of event_type total). Peak single-year volume reaches 8,042 reports across 12 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

8,150
Total Reports
2
Event-type Death
4
Injury Reports
4
Device Types

Event Types

Malfunction 8,144 (99.9%)
Injury 4 (0.0%)
Death 2 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

8,067 (99.0%)
Other 38 (0.5%)
Hospitalization 20 (0.2%)
Required Intervention 13 (0.2%)
Congenital Anomaly 5 (0.1%)
Life Threatening 4 (0.0%)
Death 2 (0.0%)
H 1 (0.0%)
R 1 (0.0%)
Disability 1 (0.0%)

Yearly Trend

10
2010: 9
13
2013: 1
15
2015: 3
16
2016: 1
18
2018: 2
19
2019: 1
20
2020: 1
21
2021: 44
22
2022: 42
23
2023: 1
24
2024: 3
25
2025: 8,042